Overview
Syllabus
Start of the analysis of Means' specific claims: @
Salami JA, et al. National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013. JAMA Cardiology. 2017; -65.
Innes GK, et al. Prescription Medication Use Among Older Adults in the US. JAMA Intern Med. 2024;121-1123.
Arshad T, et al. Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007-2016. Hepatol Commun. 2021;76-1688.
Perumpail BJ, et al. The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults.J Pediatr Gastroenterol Nutr. 2024;0-118.
Liu J, et al. Trends in Prediabetes Among Youths in the US From 1999 Through 2018. JAMA Pediatr. 2022;18-611.
Watson KB. Trends in Multiple Chronic Conditions Among US Adults, By Life Stage, Behavioral Risk Factor Surveillance System, 2013-2023. Prev Chronic Dis 2025;0539.
Kessler RC, et al. Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;3-602.
Lee YTH, et al. Prevalence and Trends of Coronary Heart Disease in the United States, 2011 to 2018. JAMA Cardiology. 2022;9-462.
Zhan Y, et al. Trends in the prevalence of Chronic Kidney Disease in the United States, 1998-2018. Front Med. 2025; 1S:99225.
Ford ES, et al. Healthy Living is the Best Revenge.Arch Intern Med. 2009;155-62.
LeCounte ES, et al. Life Expectancy at Birth in Milwaukee County: A Zip Code-Level Analysis. J Patient Cent Res Rev. 2017;3–220.
Locke DP, et al. Comparative and demographic analysis of orang-utan genomes. Nature. 2011;49-533.
Taught by
Strong Medicine